FindTrial
Sign In

LASIK Surgery

Corneal collagen cross linking with Riboflavin and UVA irradiation in Keratoconus-effects and complications.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/06/014420
Enrollment
100
Registered
2018-06-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: NIL: NIL

Sponsors

Giridhar Eye Institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: (a) All patients diagnosed as keratoconus and undergoing epithelium off corneal collagen cross linking procedure (b) Keratoconus diagnosis determined clinically and topographically.

Exclusion criteria

Exclusion criteria: Patients with history ocular trauma, corneal surgery, ocular herpes simplex infection, recurrent corneal erosion, other corneal or conjunctival diseases and systemic treatment with high doses of steroids.

Design outcomes

Primary

MeasureTime frame
This prospective study assesses the efficacy of CXL in stabilizing the cornea in keratoconus and the complications arising following the procedureTimepoint: 19 Months—

Secondary

MeasureTime frame
The results of this study might be able to stress the importance of corneal collagen cross linking in treatment of keratoconus and in improving the quality of patientâ??s life.Timepoint: 19 Months—

Countries

India

Contacts

Public ContactDr Vinay Sukumara Pillai

Giridhar Eye Institute

maayatj@gmail.com9447994706

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026